Search Results - "Laorden, Daniel"

Clasificación del neumomediastino según su etiología: aclaraciones sobre la nomenclatura by Lorente-González, Miguel, Terán-Tinedo, José R., Zevallos-Villegas, Annette, Laorden, Daniel, Suárez-Ortiz, Miguel, Ortega-Fraile, Ma. Ángeles, Cano-Sanz, Eduardo, Hernández-Núñez, Joaquín, Villén-Villegas, Tomás, Saiz-Lou, Elena Ma, Landete, Pedro

Get full text

SARS-CoV-2 Pneumonia, Acute Pulmonary Infarction Secondary to Acute Pulmonary Embolism, Secondary Spontaneous Pneumothorax and Subacute Invasive Pulmonary Aspergillosis: Are They Related to Each Other? by Lorente-González, Miguel, García-Fadul, Christian, Gijón-Herreros, Natalia, Terán-Tinedo, José Rafael, Zevallos-Villegas, Annette, Laorden, Daniel, Landete, Pedro

Get full text

Benralizumab in eosinophilic granulomatosis with polyangiitis by Laorden, Daniel, Romero, David, Domínguez-Ortega, Javier

Get full text

Anti-IL-5 and anti-IL-5R biologics for severe asthma. Are there any differences in their effects? by Granda, Paula, Villamañán, Elena, Carpio, Carlos, Laorden, Daniel, Quirce, Santiago, Álvarez-Sala, Rodolfo

“…The aim of this retrospective multicentre study is to describe the clinical characteristics of patients diagnosed with severe eosinophilic asthma receiving…”
Get full text

A comparison of the impact of anti-IL5/5R therapies in allergic versus non-allergic patients with severe eosinophilic asthma in a real-life setting by Navarro-Cascales, Tatiana, Colque-Bayona, Monica, Fernandez-Concha, Inés, Laorden, Daniel, Quirce, Santiago, Domínguez-Ortega, Javier

“…This study aimed to compare the clinical characteristics and treatment outcomes of allergic patients (AP) and non-allergic patients (NAP) with severe…”
Get full text

Cost-effectiveness and resource use analysis of patients with asthma before and after treatment with mepolizumab in a real-life setting by Domínguez-Ortega, Javier, Laorden, Daniel, Vílchez-Sánchez, Francisca, Bañas-Conejero, David, Quirce, Santiago

“…To define the cost-effectiveness and health resource use of mepolizumab in a cohort of patients with severe eosinophilic asthma in real-life conditions in…”
Get full text

Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R by Laorden, Daniel, Zamarrón, Ester, Romero, David, Domínguez-Ortega, Javier, Villamañán, Elena, Losantos, Itsaso, Gayá, Francisco, Quirce, Santiago, Álvarez-Sala, Rodolfo

“…•The FEOS score and Upham criteria are useful tools that help the clinician in clinical practice.•Both tools can help to make a decision in maintain or…”
Get full text

Long COVID outcomes in an asthmatic cohort and its implications for asthma control by Laorden, Daniel, Domínguez-Ortega, Javier, Carpio, Carlos, Barranco, Pilar, Villamañán, Elena, Romero, David, Quirce, Santiago, Álvarez-Sala, Rodolfo, Camperos, Ricardo, De Agrela, Isamar, Fernández-Concha, Inés, Ernesto Freund, Paul Kent, Pavón, Jaime, Pose, Katherine

“…•COVID-19 infection had not an influence on asthma outcomes.•There is a potential protection of T2-asthma against acute COVID infection.•The severity of asthma…”
Get full text

Successful Long-Term Treatment Combining Omalizumab and Anti-IL-5 Biologics in Allergic Bronchopulmonary Aspergillosis by Laorden, Daniel, Zamarrón, Ester, Domínguez-Ortega, Javier, Romero, David, Quirce, Santiago, Álvarez-Sala, Rodolfo

Get full text

Factors associated with suboptimal response to monoclonal antibodies in severe asthma by Pérez de Llano, Luis, Marina Malanda, Nuria, Urrutia, Isabel, Martínez‐Moragón, Eva, Gullón‐Blanco, José Antonio, Díaz‐Campos, Rocío, Esquerre, Mariana Muñoz, Mena, Alicia Habernau, Cosío, Borja G., Cisneros, Carolina, Polo, Francisco Javier Lázaro, Laorden, Daniel, Dacal Rivas, David

Get full text

Benralizumab in eosinophilic granulomatosis with polyangiitis by Laorden, Daniel, Romero, David, Domínguez-Ortega, Javier

Get more information

Adherence to inhalers in patients with severe asthma treated with anti-interleukin-5 biologics by Granda, Paula, Villamañán, Elena, Carpio, Carlos, Laorden, Daniel, Sobrino, Carmen, Herrero, Alicia, Quirce, Santiago, Álvarez-Sala, Rodolfo

“…Given poor medication adherence in severe asthma is difficult to evaluate in daily practice, using at least two methods concurrently is recommended. We aimed…”
Get full text

A real-life cohort of mepolizumab treatment in severe eosinophilic asthma by Laorden, D, Hernández, I, Domínguez-Ortega, J, Romero, D, Álvarez-Sala, R, Quirce, S

“…Mepolizumab, a monoclonal antibody that interacts with IL-5, was the first anti-IL-5 approved for uncontrolled severe eosinophilic asthma. In several…”
Get full text

Severe SARS-CoV-2 Pneumonia and Pneumomediastinum/Pneumothorax: A Prospective Observational Study in an Intermediate Respiratory Care Unit by Lorente-González, Miguel, Terán-Tinedo, José Rafael, Zevallos-Villegas, Annette, Laorden, Daniel, Mariscal-Aguilar, Pablo, Suárez-Ortiz, Miguel, Cano-Sanz, Eduardo, Ortega-Fraile, María Ángeles, Hernández-Núñez, Joaquín, Falcone, Adalgisa, Saiz-Lou, Elena María, Plaza-Moreno, María Cristina, García-Fadul, Christian, Valle-Falcones, Manuel, Sánchez-Azofra, Ana, Funes-Moreno, Clotilde, De-La-Calle-Gil, Isabel, Navarro-Casado, Rosalía, Carballo-López, Daniel, Gholamian-Ovejero, Soraya, Gallego-Rodríguez, Berta, Villén-Villegas, Tomás, Landete, Pedro

“…Introduction The occurrence of pneumomediastinum (PM) and/or pneumothorax (PTX) in patients with severe pneumonia due to severe acute respiratory syndrome…”
Get full text

Clinical Findings and Outcomes From Subjects With COVID-19 Pneumonia in an Intermediate Respiratory Care Unit by Laorden, Daniel, Gholamian-Ovejero, Soraya, Terán-Tinedo, José Rafael, Lorente-González, Miguel, Cano-Sanz, Eduardo, Ortega-Fraile, María Ángeles, Alejos, Roberto-Martínez, Hernández-Nuñez, Joaquín, De La Calle-Gil, Isabel, Navarro-Casado, Rosalía, Neria, Fernando, Zevallos-Villegas, Annette, Mariscal-Aguilar, Pablo, Suarez-Ortiz, Miguel, Plaza-Moreno, María Cristina, Carballo-López, Daniel, Gallego-Rodríguez, Berta, Calderón-Alcala, Mariara, Latif-Essa, Aylaf, Churruca-Arróspide, María, Valle-Falcones, Manuel, Saiz-Lou, Elena María, Rodríguez-Calle, Carmen, Funes-Moreno, Clotilde, Villén-Villegas, Tomas, Landete, Pedro

“…Many patients with COVID-19 require respiratory support and close monitoring. Intermediate respiratory care units (IRCU) may be valuable to optimally and…”
Get full text

Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study by Domingo Ribas, Christian, Carrillo Díaz, Teresa, Blanco Aparicio, Marina, Martínez Moragón, Eva, Banas Conejero, David, Sánchez Herrero, M. Guadalupe

Get full text

El neumomediastino como complicación de la neumonía por SARS-CoV-2 by Lorente-González, Miguel, Terán-Tinedo, José R., Zevallos-Villegas, Annette, Laorden, Daniel, Suárez-Ortiz, Miguel, Ortega-Fraile, Ma. Ángeles, Cano-Sanz, Eduardo, Hernández-Núñez, Joaquín, Villén-Villegas, Tomás, Saiz-Lou, Elena M., Landete, Pedro

Get full text

Krebs von den Lungen-6 (KL-6) Levels in Post-COVID Follow-Up: Differences According to the Severity of COVID-19 by Carpio, Carlos, Qasem, Ana, Buño, Antonio, Borobia, Alberto M, Arnalich, Francisco, Rey, Vega, Lázaro, Teresa, Mariscal, Pablo, Laorden, Daniel, Salgueiro, Giorgina, Moreno, Alberto, Peiró, Concepción, Lorenzo, Óscar, Álvarez-Sala, Rodolfo

“…To evaluate KL-6 levels in medium-term post-COVID and to compare them in three groups categorised by the severity of COVID-19, we conducted a real-world,…”
Get full text

Cardiovascular Events in Patients with Severe Asthma-A Retrospective Study of Two Cohorts: Asthma Type T2 Treated with Biologics and Non-Type T2 by Granda, Paula, Villamañán, Elena, Laorden, Daniel, Carpio, Carlos, Collada, Victoria, Domínguez-Ortega, Javier, de Las Vecillas, Leticia, Romero-Ribate, David, Chaparro-Díaz, Omar Fabián, Lázaro Miguel-Sin, Teresa, Alloca-Álvarez, Daniela Jose, Correa-Borit, Jorge Mauricio, Losantos, Itsaso, Mir-Ihara, Patricia, Narváez-Fernández, Emilio José, Quirce, Santiago, Álvarez-Sala, Rodolfo

“…: The prevalence of cardiovascular events (CVEs) in patients with asthma varies amongst studies, with little evidence as to their prevalence in patients…”
Get full text

Successful Long-Term Treatment Combining Omalizumab and Anti-IL-5 Biologics in Allergic Bronchopulmonary Aspergillosis by Laorden, Daniel, Zamarrón, Ester, Domínguez-Ortega, Javier, Romero, David, Quirce, Santiago, Álvarez-Sala, Rodolfo

Get full text